Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
D000818:Animals; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D012516:Osteosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D010100:Oxygen; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D013997:Time Factors; D014185:Transplantation, Isogeneic
D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D010100:Oxygen